First report of autologous cord blood transplantation in the treatment of a child with leukemia

Pediatrics

Volumn 119, Issue 1, 2007, Pages

  Hayani, Ammar ^a,e   Lampeter, Eberhard ^b,c   Viswanatha, David ^d   Morgan, David ^a   Salvi, Sharad N ^a  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

^b VITA34 International AG   (Germany)

^c CorCell Inc ^*  (United States)

^d MAYO CLINIC   (United States)

^e ADVOCATE CHILDREN S HOSPITAL   (United States)

Author keywords

Autologous; Leukemia; Stem cell; Transplantation; Umbilical cord blood

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; MYELOABLATIVE AGENT; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANAMNESIS; ARTICLE; BLOOD AUTOTRANSFUSION; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DRUG MEGADOSE; FEMALE; HEMATOPOIESIS; HUMAN; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; UMBILICAL CORD BLOOD; ACUTE LYMPHOCYTIC LEUKEMIA; AUTOTRANSPLANTATION; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; HEALTH CARE FACILITY; RECURRENT DISEASE; REMISSION;

CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; RECURRENCE; REMISSION INDUCTION; TISSUE BANKS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33846910901     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1009     Document Type: Article

References (19)

1. Ritchey AK, Pollock BH, Lauer SJ, Andejeski Y, Barredo J, Buchanan GR. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study [published correction appears in J Clin Oncol. 2000;18:703]. J Clin Oncol. 1999;17:3745-3752
2. Yoshihara T, Morimoto A, Kuroda H, et al. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experience and review of the literature. Bone Marrow Transplant. 2006;37:25-31
3. Bordigoni P, Esperou H, Souillet G, et al. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with ALL after relapse while receiving chemotherapy: a Societe Francaise de Greffe de Moelle study. Br J Haematol. 1998;102:656-665
4. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med. 1989;321:1174-1178
5. Tse W, Laughlin MJ. Umbilical cord blood transplantation: a new alternative option. Hematology Am Soc Hematol Educ Program. 2005:377-383
6. Fasching K, Panzer S, Haas OA, Marschalek R, Gadner H, Panzer-Grumayer ER. Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia. Blood. 2000;95:2722-2724
7. Taub JW, Konrad MA, Ge Y, et al. High frequency of leukemic clone in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood. 2002;99:2992-2996
8. Yagi T, Hibi S, Tabata Y, et al. Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood. 2000;96:264-268
9. Greaves M. Pre-natal origin of childhood leukemia. Rev Clin Exp Hematol. 2003;7:233-245
10. Mori H, colman SM, Xiao Z, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci U S A. 2002;99:8242-8247
11. Smith MA, Gloeckler Ries LA. Childhood cancer: incidence, survival, and mortality. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002
12. Johnson LF. Placental blood transplantation and autologous banking: caveat emptor. J Pediatr Hematol Oncol. 1997;19:183-186
13. Annas GJ. Waste and longing: the legal status of placental-blood banking. N Engl J Med. 1999;340:1521-1524
14. Spurr EE, Wiggins NE, Marsden KA, Lowenthal RM, Ragg SJ. Cryopreserved human hematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage. Cryobiology. 2002;44:210-217
15. Kobylka P, Ivanvi P, Breur-Vriesendorp BS. Preservation of immunological and colony-forming capacities of long-term (15 years) cryopreserved cord blood cells. Transplantation. 1998;65:1275-1278
16. Zipursky A. Fetal origin of leukemia and autologous cord blood transfusions. Pediatr Res. 2000;47:574
17. Surbek DV, Holzgreve W. Stem cells from cord blood: current status and future potential [in German]. Ther Umsch. 2002;59:577-582
18. Ferreira E, Pasternak J, Bacal N, de Campos Guerra JC, Mitie Watanabe F. Autologous cord blood transplantation. Bone Marrow Transplant. 1999;24:1041
19. Fruchtman SM, Hurlet A, Dracker R, et al. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biol Blood Marrow Transplant. 2004;10:741-742